Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy https://www.kusajili.fr:443/Trial/yKdVZDPR-kOkCRxbp7SHIw%24a-randomized-double-blind-placebo-controlled-parallel-26-week-phase-3-study-of-2-doses-of-an-alpha-7-nicotinic-acetylcholine-re
I have read and accept the terms of use of the site and the Privacy Policy
Send your message